We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Charm is a peer-to-peer impact investment platform that allows a user to use his/her investments to drive positive change in the world while earning a financial return. Morgan Stanley estimates that 85% of people are interested in sustainable investing. Charm enables individuals to fund projects led by high-impact entrepreneurs selling clean energy solutions in developing economies. Users can view their investments on the company's transparent, personalised impact investment dashboard, as well as, earn social, environmental and financial bottom line returns for their contributions. The company secured a £496,000 grant funding to develop its platform, refine its offering & provide growth capital. It is in the process of becoming an appointed representative of a Financial Conduct Authority (FCA) authorised entity post this funding round. It will use the investment to expand its team, develop its platform, and raise brand awareness.

Pitch Rated

82%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £273,720
A thought leadership media platform working with trusted experts to bring innovative advancements to organisations through journalism. The Future Shapers aims to re-imagine how information is delivered globally and the ways it can help small to large communities innovate further, avoiding the use of advertisers and paywalls.
days to go: Expired investment: £41,610
Chip is a wealth investing & savings app that aims to foster financial prosperity for today's generation
days to go: Expired investment: £5,083,686
A personal fitness app that aims to provide affordable and accessible training on demand. Auro offers classes for specific needs via an audio coach; from increasing stamina, to losing weight. Each class includes a motivational trainer with a dedicated playlist. The company also utilises artificial intelligence to personalise workout programmes for each user and has filed a patent for this technology. Auro’s app has already received more than 10k downloads and is backed by top investors, such as the founders of LoveFilm, Zoopla and Passion Capital. The company is raising funds to scale the business further in the UK and expand into Europe.
days to go: Expired investment: £262,230
Total Be wants to bring an internationally recognised model of car insurance to the UK. It provides insurance for the car, not just for an individual driver. Additionally, it does not take crime data into account that is not specific to vehicles. Thus, this insurance is estimated to provide up to 25% cheaper cover in comparison to UK insurance. Moreover, a UK Government Petition for this insurance model has gained over 60,000+ signatures, which further validates the demand of this model. Total Be believes that it will be able to disrupt the UK market with this car insurance model.
days to go: Expired investment: £150,760
Fairer Finance (FF) is a consultancy launched in 2014, on a mission to become the UK's most trusted provider of consumer financial services ratings. FF makes money through four key channels namely, licensing access to its data and insights, selling endorsements to those who do well in its ratings, sponsored research that helps improve the financial services market, and helping firms do better for their customers. FF earned £170,000 worth of revenues in its latest quarter, had its ratings published on thetimes.co.uk, which got 35 million views/week and onboarded noted entity, Lloyds Bank, that uses FF's data insights. The company aims to expand into more banking and insurance sectors and grow its consumer presence, helping it to strike deals with comparison sites and sign up more companies for its Insight services. The company will use the investment to expand its campaigning work and create a fairer market for consumers.

Pitch Rated

82%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £291,899
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph